Literature DB >> 1661299

Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain.

R Parrilla1, A J Mixson, J A McPherson, J H McClaskey, B D Weintraub.   

Abstract

Genetic analysis in our laboratory of families with generalized thyroid hormone resistance (GTHR) has demonstrated tight linkage with a locus, c-erbA beta, encoding a nuclear T3 receptor. Three point mutations and two deletions in this locus have previously been reported in affected individuals in unrelated families as potential molecular bases for this disorder. In the present study, we have used direct sequencing of polymerase chain reaction-amplified exons of the c-erbA beta gene to rapidly identify novel point mutations from seven previously uncharacterized kindreds with GTHR. Six single base substitutions and one single base insertion were identified and found to be clustered in two regions of exons 9 and 10 in the ligand binding domain of the receptor: in the distal ligand-binding subdomain L2 and across the juncture of the taui and dimerization subdomains. Reduction of T3-binding affinity in each of four mutations tested as well as segregation of all mutations to clinically affected individuals strongly supports the hypothesis that these changes are the cause of GTHR in these kindreds. In view of the diversity of clinical phenotypes manifested, the distinct topographic clustering of the mutations provides an invaluable genetic tool for the molecular dissection of thyroid receptor function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661299      PMCID: PMC295818          DOI: 10.1172/JCI115542

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Thyroid hormone receptor mutations that interfere with transcriptional activation also interfere with receptor interaction with a nuclear protein.

Authors:  A L O'Donnell; E D Rosen; D S Darling; R J Koenig
Journal:  Mol Endocrinol       Date:  1991-01

2.  The progesterone receptor stimulates cell-free transcription by enhancing the formation of a stable preinitiation complex.

Authors:  L Klein-Hitpass; S Y Tsai; N L Weigel; G F Allan; D Riley; R Rodriguez; W T Schrader; M J Tsai; B W O'Malley
Journal:  Cell       Date:  1990-01-26       Impact factor: 41.582

3.  Molecular basis of base substitution hotspots in Escherichia coli.

Authors:  C Coulondre; J H Miller; P J Farabaugh; W Gilbert
Journal:  Nature       Date:  1978-08-24       Impact factor: 49.962

4.  Familial syndrome combining deaf-mutism, stuppled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormone.

Authors:  S Refetoff; L T DeWind; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

5.  Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone.

Authors:  A Sakurai; T Miyamoto; S Refetoff; L J DeGroot
Journal:  Mol Endocrinol       Date:  1990-12

6.  A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance.

Authors:  S J Usala; J B Menke; T L Watson; W E Bérard; C Bradley; A E Bale; R W Lash; B D Weintraub
Journal:  J Clin Endocrinol Metab       Date:  1991-01       Impact factor: 5.958

7.  An essential role of domain D in the hormone-binding activity of human beta 1 thyroid hormone nuclear receptor.

Authors:  K H Lin; C Parkison; P McPhie; S Y Cheng
Journal:  Mol Endocrinol       Date:  1991-04

8.  A homozygous deletion in the c-erbA beta thyroid hormone receptor gene in a patient with generalized thyroid hormone resistance: isolation and characterization of the mutant receptor.

Authors:  S J Usala; J B Menke; T L Watson; F E Wondisford; B D Weintraub; J Bérard; W E Bradley; S Ono; O T Mueller; B B Bercu
Journal:  Mol Endocrinol       Date:  1991-03

9.  3,5,3'-triiodothyronine (T3) receptor-auxiliary protein (TRAP) binds DNA and forms heterodimers with the T3 receptor.

Authors:  D S Darling; J S Beebe; J Burnside; E R Winslow; W W Chin
Journal:  Mol Endocrinol       Date:  1991-01

10.  Filter-binding assay procedure for thyroid hormone receptors.

Authors:  A Inoue; J Yamakawa; M Yukioka; S Morisawa
Journal:  Anal Biochem       Date:  1983-10-01       Impact factor: 3.365

View more
  88 in total

1.  Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene.

Authors:  M J McPhaul; M Marcelli; S Zoppi; C M Wilson; J E Griffin; J D Wilson
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

Review 2.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

Review 3.  New insights into regulation of lipid metabolism by thyroid hormone.

Authors:  Xuguang Zhu; Sheue-yann Cheng
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-10       Impact factor: 3.243

4.  Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor.

Authors:  Hao Ying; Osamu Araki; Fumihiko Furuya; Yasuhito Kato; Sheue-Yann Cheng
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

5.  Alpha and beta thyroid hormone receptor (TR) gene expression during auditory neurogenesis: evidence for TR isoform-specific transcriptional regulation in vivo.

Authors:  D J Bradley; H C Towle; W S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone.

Authors:  Hao Ying; Fumihiko Furuya; Mark C Willingham; Jianming Xu; Bert W O'Malley; Sheue-Yann Cheng
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

7.  Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors.

Authors:  Kristen R Vella; Preeti Ramadoss; Ricardo H Costa-E-Sousa; Inna Astapova; Felix D Ye; Kaila A Holtz; Jamie C Harris; Anthony N Hollenberg
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

Review 8.  Lessons from mouse models of thyroid cancer.

Authors:  Caroline S Kim; Xuguang Zhu
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

9.  Phenotypic variability in patients with generalised resistance to thyroid hormone.

Authors:  J Pohlenz; S Wirth; A Winterpacht; H Wemme; B Zabel; W Schönberger
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

10.  PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.

Authors:  C J Guigon; L Zhao; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2008-11-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.